Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/32398

OpenURL Link
Title
The role of pharmacoeconomics in formulary decision-making: considerations for hospital and managed care pharmacy and therapeutics committees
Author/Creator
Walkom, Emily;  Robertson, Jane;  Newby, David;  Pillay, Thamizhanban
Description
The role of cost- and pharmacoeconomic-related criteria in formulary decision-making was assessed in a literature review of 31 studies of hospital (n=18) and managed care (n=13) pharmacy and therapeutics (P&T) committees. In both settings, cost was important, although the elements of cost considered varied. Acquisition cost was mentioned more frequently than pharmacoeconomic or cost-effectiveness information. Other factors, including drug characteristics, quality of life, supply-related issues, and physician demand, also influenced decisions. Despite the relatively low reported usage of pharmacoeconomic data in decision-making, most respondents considered the information to be "somewhat" or "very" important. Barriers to the use of pharmacoeconomic information included institutional factors and lack of training. Limitations in the survey methods used and issues considered restricted the ability to identify a comprehensive and consistent role for cost information in selecting formulary drugs. Further research on the use of pharmacoeconomic information is required.
Relation
Formulary Vol. 41, Issue 8, p. 374-385
Relation
http://www.formularyjournal.com/formulary/Pharmacy/The-role-of-pharmacoeconomics-in-formulary-decisio/ArticleStandard/Article/detail/364692
Date
2006
Publisher
Advanstar Communications
Keyword(s)
formulary decision-making;  pharmacoeconomic;  pharmacy and therapeutics committees;  hospitals;  managed care
Resource Type
journal article
Identifier
http://hdl.handle.net/1959.13/32398
Identifier
ISSN:1082-801X
Reviewed
Reviewed
112 Visitors 120 Hits 0 Downloads
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Formulary"
 
OR